United Therapeutics Corporation (UTHR) Social Stream
UNITED THERAPEUTICS CORP (UTHR) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering UNITED THERAPEUTICS CORP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 9 | $276 | $135 | $234.375 | $229.4 | 2.17% |
| 2022-01-21 | 8 | $276 | $135 | $235 | $229.4 | 2.44% |
| 2022-02-10 | 9 | $276 | $135 | $235.625 | $229.4 | 2.71% |
| 2022-02-25 | 10 | $276 | $135 | $235.625 | $229.4 | 2.71% |
| 2022-03-28 | 10 | $275 | $135 | $223.75 | $229.4 | -2.46% |
| 2022-04-22 | 10 | $275 | $135 | $222.875 | $229.4 | -2.84% |
| 2022-05-23 | 10 | $300 | $140 | $228.375 | $229.4 | -0.45% |
| 2022-05-24 | 10 | $300 | $140 | $241.375 | $229.4 | 5.22% |
| 2022-07-15 | 9 | $300 | $135 | $242 | $229.4 | 5.49% |
| 2022-07-22 | 9 | $300 | $140 | $242.625 | $229.4 | 5.77% |
| 2022-08-05 | 9 | $325 | $142 | $250.25 | $229.4 | 9.09% |
| 2022-09-20 | 9 | $325 | $142 | $249.5 | $229.4 | 8.76% |
| 2022-10-03 | 9 | $325 | $142 | $247.875 | $229.4 | 8.05% |
| 2022-10-21 | 10 | $325 | $135 | $251.333 | $229.4 | 9.56% |
| 2022-11-01 | 10 | $325 | $142 | $252.111 | $229.4 | 9.9% |
| 2022-11-03 | 10 | $375 | $150 | $277.333 | $229.4 | 20.89% |
| 2022-11-29 | 10 | $375 | $150 | $286.333 | $229.4 | 24.82% |
| 2022-12-05 | 12 | $375 | $150 | $280.7 | $229.4 | 22.36% |
| 2022-12-07 | 12 | $375 | $150 | $285 | $229.4 | 24.24% |
| 2023-01-05 | 12 | $375 | $150 | $287.272 | $229.4 | 25.23% |
| 2023-02-08 | 13 | $375 | $150 | $287.272 | $229.4 | 25.23% |
| 2023-02-22 | 12 | $375 | $150 | $287.272 | $229.4 | 25.23% |
| 2023-02-23 | 12 | $375 | $230 | $300.2 | $229.4 | 30.86% |
| 2023-03-22 | 12 | $375 | $150.001 | $286.545 | $229.4 | 24.91% |
| 2023-04-10 | 12 | $375 | $150.001 | $286.181 | $229.4 | 24.75% |
| 2023-05-01 | 12 | $375 | $150 | $285.272 | $229.4 | 24.36% |
| 2023-05-04 | 12 | $375 | $150 | $281.545 | $229.4 | 22.73% |
| 2023-06-06 | 12 | $375 | $160 | $281.636 | $229.4 | 22.77% |
| 2023-07-11 | 11 | $375 | $160 | $282.7 | $229.4 | 23.23% |
| 2023-07-12 | 11 | $375 | $160 | $283.7 | $229.4 | 23.67% |
| 2023-08-03 | 11 | $375 | $170 | $285.1 | $229.4 | 24.28% |
| 2023-10-11 | 11 | $375 | $170 | $286.3 | $229.4 | 24.8% |
| 2023-10-30 | 12 | $375 | $170 | $286.636 | $229.4 | 24.95% |
| 2023-11-03 | 12 | $375 | $177 | $292.7 | $229.4 | 27.59% |
| 2023-12-08 | 13 | $375 | $177 | $294.181 | $229.4 | 28.24% |
| 2023-12-15 | 14 | $375 | $178 | $294.272 | $229.4 | 28.28% |
The Trend in the Analyst Price Target
UTHR's average price target has moved up $79.71 over the prior 31 months.
UTHR reports an average of 24.21% for its upside potential over the past 46 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-23 | 12 | 375 | 230.000 | 300.200 | 248.36 | 20.87% |
| 2023-04-10 | 12 | 375 | 150.001 | 286.181 | 223.07 | 28.29% |
| 2023-05-04 | 12 | 375 | 160.000 | 281.636 | 215.72 | 30.56% |
| 2023-06-06 | 12 | 375 | 160.000 | 282.700 | 220.25 | 28.35% |
| 2023-08-03 | 11 | 375 | 170.000 | 286.300 | 231.87 | 23.47% |
UTHR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.54 | 11 | 0 | 0 | 1 | 1 | 13 |
The Trend in the Broker Recommendations
UTHR's average broker recommendation rating improved by 0.64 over the prior 46 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how UNITED THERAPEUTICS CORP fares relative to all US stocks, note that its average analyst price target is greater than 4287.78% of that group.
- In terms of how UNITED THERAPEUTICS CORP fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 961.39% of that group.
- UTHR has a lower variance in analysts' estimates than -3511.69% of stocks in the large market cap category.
- In the context of Pharmaceutical Products stocks, UNITED THERAPEUTICS CORP's number of analysts covering the stock is greater than 3360.9% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to UNITED THERAPEUTICS CORP are BMRN, VRTX, and RPRX.
View All Top Stocks by Price Target
Is UTHR a Buy, Hold or Sell? See the POWR Ratings now!